|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang
S, Xie S, Liu Q, Liu T, Huang J, et al: Transcriptional patterns,
biomarkers and pathways characterizing nasopharyngeal carcinoma of
Southern China. J Transl Med. 6(32)2008. View Article : Google Scholar
|
|
3
|
Chou J and Lin YC: Nasopharyngeal
carcinoma-review of the molecular mechanisms of tumorigenesis. Head
Neck. 30:946–963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang R, Wu F, Lu H, Wei B, Feng G, Li G,
Liu M, Yan H, Zhu J, Zhang Y and Hu K: Definitive
intensity-modulated radiation therapy for nasopharyngeal carcinoma:
Long-term outcome of a multicenter prospective study. J Cancer Res
Clin Oncol. 139:139–145. 2013. View Article : Google Scholar
|
|
6
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brabletz T: EMT and MET in metastasis:
Where are the cancer stem cells? Cancer Cell. 22:699–701. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cai LM, Lyu XM, Luo WR, Cui XF, Ye YF,
Yuan CC, Peng QX, Wu DH, Liu TF, Wang E, et al: EBV-miR-BART7-3p
promotes the EMT and metastasis of nasopharyngeal carcinoma cells
by suppressing the tumor suppressor PTEN. Oncogene. 34:2156–2166.
2015. View Article : Google Scholar
|
|
10
|
Xia L, Huang W, Tian D, Zhu H, Qi X, Chen
Z, Zhang Y, Hu H, Fan D, Nie Y and Wu K: Overexpression of forkhead
box C1 promotes tumor metastasis and indicates poor prognosis in
hepatocellular carcinoma. Hepatology. 57:610–624. 2013. View Article : Google Scholar
|
|
11
|
Paylakhi SH, Moazzeni H, Yazdani S,
Rassouli P, Arefian E, Jaberi E, Arash EH, Gilani AS, Fan JB, April
C, et al: FOXC1 in human trabecular meshwork cells is involved in
regulatory pathway that includes miR-204, MEIS2 and ITGβ1. Exp Eye
Res. 111:112–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khan AO, Aldahmesh MA, Mohamed JY and
Alkuraya FS: Congenital glaucoma with acquired peripheral
circumferential iris degeneration. J AAPOS. 17:105–107. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ray PS, Wang J, Qu Y, Sim MS, Shamonki J,
Bagaria SP, Ye X, Liu B, Elashoff D, Hoon DS, et al: FOXC1 is a
potential prognostic biomarker with functional significance in
basal-like breast cancer. Cancer Res. 70:3870–3876. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu ZY, Ding SM, Zhou L, Xie HY, Chen KJ,
Zhang W, Xing CY, Guo HJ and Zheng SS: FOXC1 contributes to
microvascular invasion in primary hepatocellular carcinoma via
regulating epithelial-mesenchymal transition. Int J Biol Sci.
8:1130–1141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Gu F, Liu CY, Wang RJ, Li J and Xu
JY: High level of FOXC1 expression is associated with poor
prognosis in pancreatic ductal adenocarcinoma. Tumour Biol.
34:853–858. 2013. View Article : Google Scholar
|
|
16
|
Nagel S, Meyer C, Kaufmann M, Drexler HG
and MacLeod RA: Deregulated FOX genes in Hodgkin lymphoma. Genes
Chromosomes. Cancer. 53:917–933. 2014.
|
|
17
|
Wei LX, Zhou RS, Xu HF, Wang JY and Yuan
MH: High expression of FOXC1 is associated with poor clinical
outcome in non-small cell lung cancer patients. Tumour Biol.
34:941–946. 2013. View Article : Google Scholar
|
|
18
|
Bloushtain-Qimron N, Yao J, Snyder EL,
Shipitsin M, Campbell LL, Mani SA, Hu M, Chen H, Ustyansky V,
Antosiewicz JE, et al: Cell type-specific DNA methylation patterns
in the human breast. Proc Natl Acad Sci USA. 105:14076–14081. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Taube JH, Herschkowitz JI, Komurov K, Zhou
AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, et
al: Core epithelial-to-mesenchymal transition interactome gene
expression signature is associated with claudin-low and
meta-plastic breast cancer subtypes. Proc Natl Acad Sci USA.
107:15449–15454. 2010. View Article : Google Scholar
|
|
20
|
Sizemore ST and Keri RA: The forkhead box
transcription factor FOXC1 promotes breast cancer invasion by
inducing matrix metalloprotease 7 (MMP7) expression. J Biol Chem.
287:24631–24640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei
RR, Zhang MY, Sun Y, Huang BJ, Chen M, et al: Prognostic value of a
microRNA signature in nasopharyngeal carcinoma: A microRNA
expression analysis. Lancet Oncol. 13:633–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th ed.
Springer; New York: 2009
|
|
23
|
Zhang XL, Huang CX, Zhang J, Inoue A, Zeng
SE and Xiao SJ: CtBP1 is involved in epithelial-mesenchymal
transition and is a potential therapeutic target for hepatocellular
carcinoma. Oncol Rep. 30:809–814. 2013.PubMed/NCBI
|
|
24
|
Thompson CC, Ashcroft FJ, Patel S, Saraga
G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE,
Lemoine NR, et al: Pancreatic cancer cells overexpress gelsolin
family-capping proteins, which contribute to their cell motility.
Gut. 56:95–106. 2007. View Article : Google Scholar
|
|
25
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pankov R and Yamada KM: Fibronectin at a
glance. J Cell Sci. 115:3861–3863. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Williams CM, Engler AJ, Slone RD, Galante
LL and Schwarzbauer JE: Fibronectin expression modulates mammary
epithelial cell proliferation during acinar differentiation. Cancer
Res. 68:3185–3192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han S, Khuri FR and Roman J: Fibronectin
stimulates non-small cell lung carcinoma cell growth through
activation of Akt/mammalian target of rapamycin/S6 kinase and
inactivation of LKB1/AMP-activated protein kinase signal pathways.
Cancer Res. 66:315–323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ramis-Conde I, Chaplain MA, Anderson AR
and Drasdo D: Multi-scale modelling of cancer cell intravasation:
The role of cadherins in metastasis. Phys Biol. 6(016008)2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ogrodnik M, Salmonowicz H, Brown R,
Turkowska J, Średniawa W, Pattabiraman S, Amen T, Abraham AC,
Eichler N, Lyakhovetsky R and Kaganovich D: Dynamic JUNQ inclusion
bodies are asymmetrically inherited in mammalian cell lines through
the asymmetric partitioning of vimentin. Proc Natl Acad Sci USA.
111:8049–8054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang W, Li X, Zhang W, Li W, Yi M, Yang J,
Zeng Z, Colvin Wanshura LE, McCarthy JB, Fan S, et al:
Oxidored-nitro domain containing protein 1 (NOR1) expression
suppresses slug/vimentin but not snail in nasopharyngeal carcinoma:
Inhibition of EMT in vitro and in vivo in mice. Cancer Lett.
348:109–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Batlle E, Sancho E, Franci C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
